NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Clinical trial registration, sponsored by M.D. Anderson Cancer Center, registered 13 Nov 2025.

Phase 2 · not yet recruiting · n = 83

Tags: Registry, Psilocybin, Pain, Cancer.

Featured in the Weekly Science Digest

• 20 Jul 2026 to 2 Oct 2026, finding 1: Psilocybin prevented chemotherapy nerve damage in mice

Read the original